It is characterized by small neuroendocrine (NE)-like cells which typically express NE markers such as chromogranin A (CHGA) and synaptophysin (SYP) and do not express androgen receptor (AR) or adenocarcinoma markers, such as prostate-specific antigen (PSA) [1, 2]. Here, KLK3 is linked to adenocarcinoma.